Rare diseases
Investigational molecules
Locations
465 North Halstead Street Suite 200, 91107-3291, United States
Xencor Inc. supports clinical research in ulcerative colitis, with interest in therapies aimed at reducing colonic and rectal inflammation and improving disease control in moderately to severely active disease.
The sponsor’s work in this area reflects a focus on immune-mediated disorders of the bowel and treatments intended to restore intestinal function.
Xencor Inc. runs clinical trials in conditions such as Colitis ulcerative, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
